As of 3:59pm ET
| +0.07 / +5.34%|
The 7 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 17.00 and a low estimate of 1.00. The median estimate represents a +44.93% increase from the last price of 1.38.
The current consensus among 9 polled investment analysts is to Hold stock in Infinity Pharmaceuticals Inc. This rating has held steady since June, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.